Conolidine’s analgesic outcomes stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors inside the central anxious technique, conolidine modulates alternate molecular targets. A Science Innovations examine found that conolidine interacts Together with the atypical chemokine receptor ACKR